May 19th, 2017

The Technology Behind Bluebird Bio

Bluebird Bio CEO Nick Leschly discusses gene therapy, Boston's biotech scene, and venture capital with Bloomberg's Caroline Hyde on "Bloomberg Technology" at the Museum of Science in Boston on May 9. (Source: Bloomberg)

Top Video

Explore More
Exclusive

Duration:2:07

JPMorgan's Dimon Sees Too Much Exuberance in Markets

Bloomberg Wall Street Week

Duration:6:43

Ed Yardeni Boosts S&P Target Amid ‘Unprecedented’ Earnings Expectations

Exclusive

Duration:0:56

Dimon Says US, Europe Have to Fix 'Stupid' Trade Issues

Duration:2:40

Trump, Xi Summit Nears Amid Backdrop of Iran War

Duration:2:04

EBay Rejects GameStop’s $56 Billion Takeover Bid

Duration:1:39

JPMorgan Says Inflation to Stay 'Persistently Higher'

Duration:2:33

UK Bonds Fall as Pressure on Starmer to Quit Grows

Duration:2:35

Korea Floats ‘Citizen Dividend’ From AI Gain

Available on:

Listen onApple TVListen onRokuListen onSamsung TVListen onFire TVListen onAndroid TVListen onRakuten TVListen onHaystack News

Watch BTV in your area:

Channel Finder
Terms of ServiceTrademarksPrivacy Policy
CareersAdvertise
Ad Choices
Help©2026 Bloomberg L.P. All Rights Reserved.